Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Directory > Products and applications > Salzburg Therapeutics

Salzburg Therapeutics

Salzburg Therapeutics is committed to developing Cytotoxamer and Genotoxamer technologies and to obtaining FDA approval to initiate human clinical trials with our lead compound. We seek funding for our drug development efforts through a combination of government grants and private equity. Salzburg Therapeutics welcomes inquiries from larger pharmaceutical companies seeking to expand their pipeline for developing new oncology products.

Website

3455 University Parkway
Winston-Salem, NC 27106 USA
336-831-5686

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE